# The Study of Intraperitoneal Docetaxel Plus S-1 for Malignant Ascites

> **NCT02779608** · PHASE2 · UNKNOWN · sponsor: **Fudan University** · enrollment: 50 (estimated)

## Conditions studied

- Stomach Neoplasms
- Peritoneal Metastasis

## Interventions

- **DRUG:** intraperitoneal docetaxel
- **DRUG:** oral S-1

## Key facts

- **NCT ID:** NCT02779608
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01-20
- **Primary completion:** 2018-06
- **Final completion:** 2018-06
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2017-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02779608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02779608, "The Study of Intraperitoneal Docetaxel Plus S-1 for Malignant Ascites". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02779608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*